1 |
3SBio Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
Aarey Drugs and Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
Aarti Drugs Ltd. (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
Aarti Drugs Ltd.(Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
Abbott India Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
Abbott Laboratories (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
Abbott Laboratories Pakistan Ltd. (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
AbbVie Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
Abeona Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
Acacia Pharma Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
ACADIA Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
AcelRx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
Acer Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
Acerus Pharmaceuticals Corporation (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
Ache Laboratorios Farmaceuticos S.A. (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2016 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
Achillion Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
ACME Laboratories Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Acreage Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
Acrux Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
Active Fine Chemicals Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Acura Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Adalta Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
Adam Capital PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
Adamas Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Adamis Pharmaceuticals Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
Addex Therapeutics Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
Adhera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Adial Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Advanced Chemical Industries Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
Advanced Medical Solutions Group plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Advanz Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Advaxis, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
7/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
Advent Pharma Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
Aeglea Bio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Aequus Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Aerie Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
AEterna Zentaris Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
AEterna Zentaris Inc. (USA) (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
AFT Pharmaceuticals Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
AgeX Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
Agile Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
Agios Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
AGP Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
Ahn-Gook Pharmaceutical Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
Ajanta Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Ajanta Pharma Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
Akcea Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Akebia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
Akorn, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
Al Kindi of Veterinary Vaccines Drugs (Iraq) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Al Mansour Pharmaceuticals Industries Co (Iraq) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Albireo Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
Alcami Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
Alder Biopharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Alembic Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Alembic Limited (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Alembic Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
Alembic Pharmaceuticals Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
Alexandria Pharma. & Chemical Industries (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
Alexion Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
Alexza Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2016 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
Alimera Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Alkaloid AD Skopje (Republic of Macedonia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Alkem Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
Alkem Laboratories Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
Alkermes Plc (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
Alkermes, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
All State Properties Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Allakos Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Allergan Finance, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Allergan plc (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
Allergan, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Allergy Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
Alliance Pharma plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
Almirall SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Alnylam Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Alpa Laboratories Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
Alpine Immune Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
Alterity Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Alterity Therapeutics Ltd (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Altimmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Alvogen Korea Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
Alvogen Pharma US, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
ALZA Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2001 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
Amarillo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
Amarin Corporation plc (ADR) (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
Ambalal Sarabhai Enterprises Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Ambalal Sarabhai Enterprises Ltd (P) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
American Bio Medica Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
American Vietnamese Biotech Inc (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
Amicus Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Amneal Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
Amphastar Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
Amryt Pharma Holdings Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Anatara Lifesciences Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
ANG Lifesciences India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Angiogenex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
AngioLab Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
AngioSoma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
Anhui Anke Biotechnology (Group) Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
101 |
Anhui Fengyuan Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
102 |
Animalcare Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
103 |
Ankur Drugs and Pharma Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2012 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
104 |
Anterogen Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
105 |
Antibiotice SA (Romania) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
106 |
Anuh Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
107 |
Anxo Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
108 |
Aphria Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
109 |
Apollo 5 Gmbh (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
110 |
Aprogen Pharmaceuticals Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
111 |
Aptevo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
112 |
Aptorum Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
113 |
Aquestive Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
114 |
Arbor Pharmaceuticals, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
115 |
Arena Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
116 |
Argos Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
117 |
Arog Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
118 |
ArQule, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
119 |
Array BioPharma Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
120 |
Ascendis Health Ltd (South Africa) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
121 |
Ascletis Pharma Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
122 |
ASKA Pharmaceutical Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
123 |
Aspen Pharmacare Holdings Limited (South Africa) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
124 |
Assembly Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
125 |
Assertio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
126 |
Astellas Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
127 |
Astrazeneca Pharma India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
128 |
AstraZeneca plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
129 |
AstraZeneca plc (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
130 |
Athenex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
131 |
Athersys, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
132 |
Atrium Innovations Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2013 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
133 |
aTyr Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
134 |
Aurinia Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
135 |
Auro Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
136 |
Aurobindo Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
137 |
Aurobindo Pharma Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
138 |
Autobio Diagnostics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
139 |
Avadel Pharmaceuticals PLC (ADR) (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
140 |
Avecho Biotechnology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
141 |
Avenue Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
142 |
AVEO Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
143 |
Avivagen Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
4/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
144 |
Avricore Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
145 |
Axim Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
146 |
Axovant Gene Therapies Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
147 |
Ayrton Drugs Manufacturing Company Ltd. (Ghana) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
148 |
AzurRx BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
149 |
Bafna Pharmaceuticals Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
150 |
Bajaj Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
151 |
Bal Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
152 |
Bausch Health Americas, Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2010 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
153 |
Bausch Health Companies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
154 |
Bausch Health Companies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
155 |
Baxalta Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2016 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
156 |
Bayer AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
157 |
Bayer AG (ADR) (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
158 |
Bayer Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
159 |
BCworld Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
160 |
BDH Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
161 |
BEACON Pharmaceuticals Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
162 |
Beijing Aosaikang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
163 |
Beijing Beilu Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
164 |
Beijing Konruns Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
165 |
Beijing Science Sun Pharmaceutical CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
166 |
Beijing Tong Ren Tang Chinese Medicine (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
167 |
Beijing Tongrentang Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
168 |
BELLUS Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
169 |
BELLUS Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
170 |
Ben Tre Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
171 |
Bespoke Extracts Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
5/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
172 |
Betta Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
173 |
Beximco Pharmaceuticals Limited (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
174 |
Bharat Immunologicals&Biologcls Corp Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
175 |
Bharat Parenterals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
176 |
Binex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
177 |
Binh Dinh Pharmctcl & Medical Eqpmnt JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
178 |
Biocept Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
179 |
Biocorp SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
180 |
BioDelivery Sciences International, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
181 |
Biodue SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
182 |
Biofarm SA (Romania) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
183 |
Biofermin Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
184 |
Biofrontera AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
185 |
Biohaven Pharmaceutical Holding Co Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
186 |
BioHemp International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
5/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
187 |
BioLineRX Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
188 |
BioMarin Pharmaceutical Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
189 |
BioPorto A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
190 |
Biosintez PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
191 |
BioSpecifics Technologies Corp. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
192 |
Biostem Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
193 |
Biosynex SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
194 |
Biotec Pharmacon ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
195 |
Biotest AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
196 |
Biotika a.s. (Slovakia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
197 |
Biotoscana Investments SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
198 |
Black Star Petroleum Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
199 |
Blau Farmaceutica SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
200 |
Bliss GVS Pharma Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
201 |
Bliss GVS Pharma Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
202 |
BNC Korea Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
203 |
BNC Korea Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
204 |
Boehringer Ingelheim GmbH (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
205 |
Boiron SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
206 |
Bone Therapeutics SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
207 |
Bora Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
208 |
Boryung Pharmaceutical Co., Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
209 |
Bosnalijek d.d. Sarajevo (Bosnia and Herzegovina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
210 |
BridgeBio Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
211 |
BrightGene Bio-Medical Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
212 |
Bristol-Myers Squibb Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
213 |
Brooks Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
214 |
BTG plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
215 |
Bukwang Pharmaceutical Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
216 |
Cadila Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
217 |
Cadila Healthcare Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
218 |
Cai Lay Veterinary Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
219 |
Calithera Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
220 |
Calliditas Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
221 |
Camarico Investment Group Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
222 |
Cambrex Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
223 |
Camurus AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
224 |
Can Fite Biopharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
225 |
Cann Global Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
226 |
Cannabis One Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
7/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
227 |
Cannapharmarx Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
228 |
Caplin Point Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
229 |
Caplin Point Laboratories Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
230 |
Capricor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
231 |
Capstone Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
232 |
Cara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
233 |
Cassava Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
234 |
Catalent Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
235 |
Catalyst Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
236 |
Catalyst Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
237 |
Cathay International Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
238 |
Celexus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
239 |
Celgene Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
240 |
Cell Source Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
241 |
Cellectar Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
242 |
Celltrion Pharm Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
243 |
Cellular Biomedicine Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
244 |
Celon Pharma SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
245 |
Celsion Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
246 |
Center Laboratories, Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
247 |
Central Pharmaceutical CPC1 JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
248 |
Central Pharmaceutical JSC No2 (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
249 |
Central Pharmaceutical JSC No3 (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
250 |
Centrexion Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
251 |
Ceva Sante Animale SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
252 |
CFR Pharmaceuticals SA (Chile) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2015 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
253 |
CGN Mining Co Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
254 |
CH Boehringer Sohn AG & Co KG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
255 |
Changzhou Qianhong Bio Pharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
256 |
Cheil Bio Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
257 |
Chem Tech Research Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
258 |
Chembio Diagnostics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
259 |
Chemcrux Enterprises Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
260 |
Chemistree Technology Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
261 |
ChemoCentryx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
262 |
Chengdu Kanghong Pharma Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
263 |
Chengdu Taihe Health Technlg Grp Inc Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
264 |
Chi Sheng Pharma & Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
265 |
Chiasma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
266 |
China Biotech Services Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
267 |
China Chemical and Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
268 |
China Grand Pha.and Healthcare Hld. Ltd. (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
269 |
China Health Industries Holdings, Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
270 |
China Medical System Holdings (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
271 |
China Pharma Holdings, Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
272 |
China Resources Pharmaceutical Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
273 |
China Resources Sanju Mdcl & Phrm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
274 |
China Shineway Pharmaceutical Group Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
275 |
China SXT Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
276 |
China Traditional Chinese Med Hldg CoLtd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
277 |
ChoA Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
278 |
Chong Kun Dang Pharmaceutical Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
279 |
Chongkundang Holdings Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
280 |
Chongqing Lummy Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
281 |
Chongqing Pharscin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
282 |
Chongqing Taiji Industry(Group)Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
283 |
Chugai Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
284 |
Cian Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
285 |
Cipher Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
286 |
Cipla Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
287 |
Cipla Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
288 |
Cipla Quality Chemical Industries Ltd (Uganda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
289 |
Cirius Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
290 |
Cisen Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
291 |
CK Life Sciences Intl (Holdings) Inc (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
292 |
Claris Lifesciences Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
293 |
Clovis Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
294 |
CMG Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
295 |
CMIC Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
296 |
Cobra Biologics Holdings Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
297 |
Cocrystal Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
298 |
Coland Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
299 |
Colinz Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
300 |
Collagen Solutions PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
301 |
Collegium Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
302 |
Columbia Care Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
303 |
Concord Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
304 |
Constellation Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
305 |
Consun Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
306 |
ContraFect Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
307 |
Coral Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
308 |
Corbus Pharmaceuticals Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
309 |
Corcept Therapeutics Incorporated (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
310 |
Corium International, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
311 |
Corline Biomedical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
312 |
Correvio Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
313 |
Correvio Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
314 |
Cortical Dynamics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
315 |
Cosmo Pharmaceuticals NV (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
316 |
Creso Pharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
317 |
Croda International Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
318 |
CSL Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
319 |
CSPC Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
320 |
CTI BioPharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
321 |
Cube&Company Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
322 |
Cumberland Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
323 |
Cure Pharmaceutical Holding Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
324 |
Cyclacel Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
325 |
CymaBay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
326 |
CytoDyn Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
327 |
Cytokinetics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
328 |
Cyxone AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
329 |
Dae Hwa Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
330 |
DaebongLS Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
331 |
Daehan New Pharm Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
332 |
Daesung Microbiological Labs, Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
333 |
Daewon Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
334 |
Daewoong Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
335 |
Daewoong Pharmaceutical Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
336 |
DAIICHI SANKYO CO., LTD.(Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
337 |
DAIICHI SANKYO COMPANY, LIMITED (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
338 |
Dal'khimfarm OAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
339 |
Dar Al Dawa Dev & Inv Co PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
340 |
Dare Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
341 |
Darya-Varia Laboratoria Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
342 |
Dawnrays Pharmaceutical Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
343 |
DBV Technologies SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
344 |
Dechra Pharmaceuticals plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
345 |
Delivra Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
346 |
Delta-Fly Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
347 |
Dendreon Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
348 |
Denis Chem Lab Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
349 |
Dermapharm Holding SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
350 |
Dermavant Sciences Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
351 |
Dermira Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
352 |
Deva Holding AS (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
353 |
DHP Korea Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
354 |
Diod PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
355 |
Diod PAO (Parent) (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
356 |
Diogene Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
357 |
Dishman Carbogen Amcis Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
358 |
Divi's Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
359 |
Divi's Laboratories Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
360 |
Dixie Brands (USA) Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
361 |
Dong-A Socio Holdings Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
362 |
Dong-A ST Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
363 |
Dong-E-E-Jiao Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
364 |
DongKoo Bio & Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
365 |
Dongkook Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
366 |
Dongsung Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
367 |
Dongwha Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
368 |
Dottikon ES Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
369 |
Dr Datsons Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
370 |
Dr.Reddy's Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
371 |
Dr.Reddy's Laboratories Ltd (ADR) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
372 |
Dr.Reddy's Laboratories Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
373 |
Duchembio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
374 |
Duopharma Biotech Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
375 |
DURECT Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
376 |
Dynavax Technologies Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
377 |
Eagle Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
378 |
Eagle Veterinary Technology Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
379 |
EastPharma Ltd. (Bermuda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
380 |
Eckert & Ziegler AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
381 |
Eco Animal Health Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
382 |
Egyptian Int'l Pharmaceutical Industries (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
383 |
EIKEN CHEMICAL CO.,LTD (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
384 |
Eisai Co., Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
385 |
Eisai Co., Ltd (ADR) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
386 |
Elanco Animal Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
387 |
Elanix Biotechnologies AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
388 |
Eli Lilly and Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
389 |
Elite Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
390 |
Elixxer Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
391 |
Emergent Biosolutions Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
392 |
Emmaus Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
393 |
Enanta Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
394 |
Endo International PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
395 |
Endocyte, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
396 |
Enlie Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
397 |
Enorama Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
398 |
Enzymatica AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
399 |
EQL Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
400 |
Equillium Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
401 |
ERBA Diagnostics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2015 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
402 |
Eris Lifesciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
403 |
Eris Lifesciences Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
404 |
Esperion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
405 |
Euro Med Laboratories Phils Inc (Philippines) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
406 |
Eurobio Scientific SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
407 |
Eusol Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
408 |
Everest Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
409 |
Evofem Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
410 |
Evoke Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
411 |
Evotec SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
412 |
Exactus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
413 |
Extrawell Pharmaceutical Holdings Ltd. (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
414 |
EyeGene Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
415 |
Eyenovia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
416 |
F D C Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
417 |
F D C Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
418 |
FAES Farma SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
419 |
Farmak PAT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
420 |
Fermenta Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
421 |
Fermenta Biotech Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
422 |
Ferozsons Laboratories Limited (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
423 |
Fibrocell Science Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
424 |
FibroGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
425 |
Fidson Healthcare PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
426 |
Fine Foods & Pharmaceuticals NTM SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
427 |
Flexion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
428 |
Foamix Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
429 |
Forest Laboratories, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
430 |
Formosa Laboratories, Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
431 |
Forward Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
432 |
Fredun Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
433 |
Fresenius Kabi Oncology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
434 |
Fujian Cosunter Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
435 |
Fulcrum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
436 |
FUREN Group Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
437 |
Fuso Pharmaceutical Industries Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
438 |
Futura Medical plc. (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
439 |
FutureChem Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
440 |
Gaia Grow Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
441 |
Galectin Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
442 |
Galenica AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
443 |
Gansu Longshenrongfa Phrmctcl Ind Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
444 |
GENERAL BIOLOGICAL CORP. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
445 |
Generex Biotechnology Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
7/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
446 |
Genocea Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
447 |
Genovate Biotechnology Co., LTD. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
448 |
Geron Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
449 |
Ginwa Enterprise (Group) Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
450 |
Glaxo Smithkline Consumer Nigeria PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
451 |
Glaxosmithkline Cnsmr Hltcr Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
452 |
GlaxoSmithKline LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
453 |
GlaxoSmithKline Pakistan Limited (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
454 |
GlaxoSmithKline Pharma Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
455 |
GlaxoSmithKline Pharmaceuticals Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
456 |
GlaxoSmithKline plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
457 |
GlaxoSmithKline plc (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
458 |
GlaxoSmithKline SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
459 |
Glenmark Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
460 |
Glenmark Pharmaceuticals Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
461 |
Godavari Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
462 |
Gold River Productions Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
463 |
Golden Throat Holdings Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
464 |
Granules India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
465 |
Granules India Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
466 |
Green Cross Cell Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
467 |
Grindeks AS (Latvia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
468 |
GT Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
469 |
Guangdong Jiaying Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
470 |
Guangdong Taiantang Pharmaceutical CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
471 |
Guangdong Zhongsheng Pharm Co.,Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
472 |
Guangxi Wuzhou Zhongheng Group Co.,Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
473 |
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
474 |
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
475 |
Guerbet SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
476 |
Gufic BioSciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
477 |
Guilin Sanjin Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
478 |
Guiyang Xintian Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
479 |
Guizhou Xinbang Pharmaceutical Co.,Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
480 |
GuiZhou YiBai Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
481 |
GZ Bailing Group Pharm. Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
482 |
H. Lundbeck A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
483 |
Hainan Poly Pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
484 |
Hainan Shuangcheng Phrmcutcls Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
485 |
Haisco Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
486 |
Halychfarm PAT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
487 |
Hana Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
488 |
HANALL BIOPHARMA (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
489 |
Handa Pharmaceuticals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
490 |
Handok Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
491 |
Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
492 |
Hanmi Science Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
493 |
HanmiPharm (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
494 |
Hansoh Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
495 |
Hao Wen Holdings Limited (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
496 |
Harbin Gloria Pharmaceuticals Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
497 |
Harbin Medisan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
498 |
Harbin Pharmaceutical Group Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
499 |
Harrow Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
500 |
Hatinh Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
501 |
Haw Par Corporation Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
502 |
Hayat Pharmaceutical Industries Comp PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
503 |
Health-Right Discoveries Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
504 |
Heat Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
505 |
Heilongjiang ZBD Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
506 |
Henan Taloph Pharmaceutical Stock Co., (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
507 |
Hengkang Medical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
508 |
Heron Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
509 |
Highnoon Laboratories Limited (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
510 |
Hikal Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
511 |
Hikal Limited (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
512 |
Hikma Pharmaceuticals Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
513 |
Hikma Pharmaceuticals Plc (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
514 |
Hillestad Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2006 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
515 |
Holy Stone Healthcare Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
516 |
Honz Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
517 |
Hookipa Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
518 |
Horizon Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
519 |
Hovid Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
520 |
Hua Han Health Industry Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2015 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
521 |
Huapont Life Sciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
522 |
Hubei Jumpcan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
523 |
Humanwell Healthcare Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
524 |
Humedix Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
525 |
Hunan Fangsheng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
526 |
Hunan Jingfeng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
527 |
Huons Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
528 |
Huons Global Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
529 |
Hutchison China MediTech Limited (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
530 |
Hybio Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
531 |
Hypera SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
532 |
Hyphens Pharma International Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
533 |
Hyundai Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
534 |
I'rom Group Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
535 |
IBN SINA Pharmaceutical Industry Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
536 |
ICC International Cannabis Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
537 |
Ideaya Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
538 |
Idorsia Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
539 |
IGM Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
540 |
Il Dong Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
541 |
Ildong Holdings Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
542 |
ILSUNG PHARMACEUTICAL CO.,LTD (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
543 |
Ilyang Pharmaceutical Co., Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
544 |
Immune Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
545 |
Immune Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
546 |
ImmunoCellular Therapeutics Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
547 |
ImmunoGen, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
548 |
Ind Swift Laboratories Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
549 |
Ind Swift Laboratories Limited (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
550 |
IND Swift Ltd. (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
551 |
InDex Pharmaceuticals Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
552 |
Indivior PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
553 |
Indoco Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
554 |
Indoco Remedies Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
555 |
Indofarma (Persero) Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
556 |
Infant Bacterial Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
557 |
Infinity Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
558 |
InMed Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
559 |
Inner Spirit Holdings Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
560 |
Innovation Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
561 |
Innoviva Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
562 |
Innovus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
563 |
Insmed Incorporated (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
564 |
Inspyr Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
565 |
Insys Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
566 |
Intarcia Therapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2005 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
567 |
Integrated BioPharma, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
568 |
Integumen PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
569 |
IntelGenx Technologies Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
570 |
IntelliPharmaCeutics International Inc (USA) (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
11/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
571 |
IntelliPharmaCeutics International Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
572 |
Inter Pharma PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
573 |
Intercept Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
574 |
International Cannabrands Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
575 |
International Stem Cell Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
576 |
Intra-Cellular Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
577 |
iNtRON Biotechnology Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
578 |
Invex Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
579 |
Ionis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
580 |
IPCA Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
581 |
IPCA Laboratories Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
582 |
Ipsen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
583 |
IRLAB Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
584 |
Ironwood Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
585 |
Isofol Medical AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
586 |
IVERIC bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
587 |
IWAKI & CO., LTD. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
588 |
IX Biopharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
589 |
J.L. Morison Son & Jones (Ceylon) PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
590 |
Jack Chia Industries (Thailand) PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
591 |
Jacobson Pharma Corporation Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
592 |
Jagsonpal Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
593 |
Jaguar Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
594 |
Jazz Pharmaceuticals PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
595 |
Jeil Pharma Holdings Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
596 |
Jeil Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
597 |
Jenburkt Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
598 |
Ji Yao Holding Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
599 |
Jiang Zhong Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
600 |
Jiangsu Hengrui Medicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
601 |
Jiangsu Kanion Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
602 |
Jiangsu Lianhuan Pharmaceutical Co. Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
603 |
Jiangxi Fuxiang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
604 |
Jiangxi Synergy Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
605 |
Jianmin Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
606 |
Jilin Aodong Medicine Industry Group Co. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
607 |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
608 |
Jilin Zixin Pharmaceutical Ind. Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
609 |
Jin Yang Pharmaceutical Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
610 |
Jinhe Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
611 |
Jinling Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
612 |
Jiuzhitang Co.,Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
613 |
Johnson & Johnson (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/29/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
614 |
Johnson & Johnson (OLD) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
615 |
Johnson Chemical Pharmactcl Works Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
616 |
Joincare Pharmaceutical Group Ind. Co. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
617 |
Jubilant Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
618 |
Jubilant Life Sciences Ltd (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
619 |
Jubilant Pharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
620 |
Juniper Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
621 |
JW Life Science Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
622 |
JW Pharmaceutical Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
623 |
JW Shinyak Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
624 |
Kadmon Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
625 |
KAKEN PHARMACEUTICAL CO., LTD. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
626 |
Kalbe Farma Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
627 |
Kannalife Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
628 |
Kappac Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
629 |
Karo Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
630 |
Katakura Industries Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
631 |
Kazia Therapeutics Ltd (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
632 |
Keryx Biopharmaceuticals (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
633 |
Kilitch Drugs (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
634 |
Kimia Biosciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
635 |
Kino Biotech Co Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
636 |
Knight Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
637 |
Kobayashi Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
638 |
KOEI CHEMICAL COMPANY, LIMITED (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
639 |
KolmarBNH Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
640 |
Korea Arlico Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
641 |
KOREA UNITED PHARM INC (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
642 |
Korean Drug Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
643 |
Kotra Industries Berhad (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
644 |
KPC Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
645 |
Krka d.d. Novo Mesto (Slovenia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
646 |
Kubota Pharmaceutical Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
647 |
Kukje Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
648 |
Kura Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
649 |
Kwality Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
650 |
Kwangdong Pharmaceutical Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
651 |
Kyivmedpreparat PAT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
652 |
KYORIN Holdings, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
653 |
Kyowa Kirin Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
654 |
Kyung Nam Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
655 |
Laboratorio Reig Jofre SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
656 |
Laboratorios Andromaco S.A. (Chile) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
3/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
657 |
Laboratorios Richmond SACIF (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
658 |
Lannett Company, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
659 |
Lansen Pharmaceutical Holdings Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
660 |
Lanzhou Foci Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
661 |
Lasa Supergenerics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
662 |
Laurus Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
663 |
Laurus Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
664 |
Lee's Pharmaceutical Holdings Limited (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
665 |
LEO Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
666 |
Les Trois Chenes SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
667 |
Lexicon Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
668 |
Liberty Health Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
8/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
669 |
LifeVantage Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
670 |
Ligand Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
671 |
Lin Bioscience Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
672 |
Lincoln Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
673 |
Lionco Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
674 |
Lipidor AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
675 |
Livzon Pharmaceutical Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
676 |
Livzon Pharmaceutical Group Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
677 |
Lixte Biotechnology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
678 |
Lonza Group AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
679 |
Lotus Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
680 |
Lotus Ventures Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
5/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
681 |
Luckwel Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
682 |
Lupin Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
683 |
Lupin Limited (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
684 |
Lyka Labs Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
685 |
Mabpharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
686 |
Mabvax Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
687 |
MacroGenics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
688 |
Macter International Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
689 |
Madrigal Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
690 |
Makers Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
691 |
Malin Corporation plc (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
692 |
Mallinckrodt PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/27/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
693 |
Mangalam Drugs and Organics Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
694 |
MannKind Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
695 |
Marinomed Biotech AG (Austria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
696 |
Marinus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
697 |
Marker Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
698 |
Marksans Pharma Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
699 |
Marksans Pharma Limited (Parent) (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
700 |
May & Baker Nigeria Plc. (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
701 |
Mayinglong Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
702 |
Mayne Pharma Group Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
703 |
Medexus Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
704 |
Median Diagnostics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
705 |
Medibio Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
706 |
Medicamen Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
707 |
MediciNova, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
708 |
MediciNova, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
709 |
Medico Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
710 |
Medicure Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
711 |
Mediwound Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
712 |
Medpacto Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
713 |
MedTech Holdings Limited (Zimbabwe) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
6/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
714 |
Mega Lifesciences Public Co Ltd (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
715 |
MEI Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
716 |
Melinta Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
717 |
Melinta Therapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
12/31/2011 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
718 |
Memphis Pharmaceutical & Chemicals Ind (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
719 |
Merck & Co., Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
CQ |
Moody's |
Fitch |
DBRS |
Morningstar |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
720 |
Merck KGaA (Germany) |
FRISK® |
Z'' |
|